Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes

被引:98
作者
Zambello, R
Facco, M
Trentin, L
Sancetta, R
Tassinari, C
Perin, A
Milani, A
Pizzolo, G
Rodeghiero, F
Agostini, C
Meazza, R
Ferrini, S
Semenzato, G
机构
[1] UNIV PADUA,DIPARTIMENTO MED CLIN & SPERIMENTALE,SCH MED,I-35128 PADUA,ITALY
[2] VICENZA HOSP,DIV HEMATOL,VICENZA,ITALY
[3] UNIV VERONA,SCH MED,HEMATOL SECT,I-37100 VERONA,ITALY
[4] UNIV GENOA,SCH MED,DEPT CLIN & EXPT ONCOL,GENOA,ITALY
[5] IST NAZL RIC CANC,I-16132 GENOA,ITALY
关键词
D O I
10.1182/blood.V89.1.201.201_201_211
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The recently cloned cytokine interteukin-15 (IL-15) shares several functional activities with IL-2 in different cell systems. Although IL-15 does not show sequence homology with IL-2, it uses components of the IL-2 receptor (IL-2R) for binding and signal transduction, namely, p75 (beta) and the p64 (gamma) chains of IL-2R. To evaluate whether IL-15 is involved in the activation of granular lymphocytes (GL) in patients with lymphoproliferative disease of granular lymphocytes (LDGL), we evaluated the ability of IL-15 to stimulate GL proliferation, cytotoxic function, and the role of IL-2R beta and gamma molecules on relevant cells. Our results show that IL-15 stimulates cell proliferation and cytotoxic activity of GL in LDGL patients. Reverse-transcriptase polymerase chain reaction (RT-PCR) and phenotypic analyses using the anti-IL-2R gamma-chain-specific TUGh4 monoclonal antibody (MoAb) indicate that both CD3(+) and CD3(-) GL express the p64 IL-2R, a result previously unknown. IL-15 activity was inhibited by antibodies against p75 and p64 IL-2R chains, while no inhibitory effects are detectable with anti-p55 IL-2R antibody. The association of anti-p75 and anti-p64 IL-2R MoAbs resulted in a nearly complete (95%) inhibition of IL-15-induced GL proliferation Using RT-PCR analysis, we demonstrated that highly purified CD3(+) and CD3(-) GL did not express mRNA for IL-15 or IL-2. By contrast, a clear-cut IL-15 mRNA signal was detected by RT-PCR in patients' peripheral blood mononuclear cells, with monocytes likely accounting for the source of IL-15 in LDGL patients. However, even in concentrated supernatants from enriched monocyte populations, we could not demonstrate the presence of IL-15 protein. Using anti-IL-15 specific MoAbs, a membrane-bound form of this cytokine was demonstrated both on CD3(+) and CD3(-) LDGL cells. By RT-PCR analysis, purified GL from these patients were found to express the message for IL-15 receptor alpha chain. Taken together, these results indicate that both CD3(+) and CD3(-) GL are stimulated by IL-15 and that this cytokine mediates its activity through the beta and gamma chains of the IL-2R, providing further suggestions for the interpretation of the mechanisms that lead to cell expansion in patients with LDGL. (C) 1997 by The American Society of Hematology.
引用
收藏
页码:201 / 211
页数:11
相关论文
共 39 条
[1]  
AGOSTINI C, 1995, J IMMUNOL, V155, P2928
[2]  
ANDERSON DM, 1995, J BIOL CHEM, V270, P29862
[3]   INTERLEUKIN (IL)-15 IS A NOVEL CYTOKINE THAT ACTIVATES HUMAN NATURAL-KILLER-CELLS VIA COMPONENTS OF THE IL-2 RECEPTOR [J].
CARSON, WE ;
GIRI, JG ;
LINDEMANN, MJ ;
LINETT, ML ;
AHDIEH, M ;
PAXTON, R ;
ANDERSON, D ;
EISENMANN, J ;
GRABSTEIN, K ;
CALIGIURI, MA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) :1395-1403
[4]   Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro [J].
Carson, WE ;
Ross, ME ;
Baiocchi, RA ;
Marien, MJ ;
Boiani, N ;
Grabstein, K ;
Caligiuri, MA .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (06) :2578-2582
[5]  
FERRARINI M, 1983, J CLIN IMMUNOL, V3, P30, DOI 10.1007/BF00919136
[6]   IL-15, A NOVEL T-CELL GROWTH-FACTOR THAT SHARES ACTIVITIES AND RECEPTOR COMPONENTS WITH IL-2 [J].
GIRI, JG ;
ANDERSON, DM ;
KUMAKI, S ;
PARK, LS ;
GRABSTEIN, KH ;
COSMAN, D .
JOURNAL OF LEUKOCYTE BIOLOGY, 1995, 57 (05) :763-766
[7]   UTILIZATION OF THE BETA-CHAIN AND GAMMA-CHAIN OF THE IL-2 RECEPTOR BY THE NOVEL CYTOKINE-IL-15 [J].
GIRI, JG ;
AHDIEH, M ;
EISENMAN, J ;
SHANEBECK, K ;
GRABSTEIN, K ;
KUMAKI, S ;
NAMEN, A ;
PARK, LS ;
COSMAN, D ;
ANDERSON, D .
EMBO JOURNAL, 1994, 13 (12) :2822-2830
[8]   CLONING OF A T-CELL GROWTH-FACTOR THAT INTERACTS WITH THE BETA-CHAIN OF THE INTERLEUKIN-2 RECEPTOR [J].
GRABSTEIN, KH ;
EISENMAN, J ;
SHANEBECK, K ;
RAUCH, C ;
SRINIVASAN, S ;
FUNG, V ;
BEERS, C ;
RICHARDSON, J ;
SCHOENBORN, MA ;
AHDIEH, M ;
JOHNSON, L ;
ALDERSON, MR ;
WATSON, JD ;
ANDERSON, DM ;
GIRI, JG .
SCIENCE, 1994, 264 (5161) :965-968
[9]  
HART DNJ, 1992, BLOOD, V79, P2116
[10]  
HORI T, 1988, J IMMUNOL, V12, P4199